Michael P. Dube

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Signature
/s/ James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael P. Dube:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. VP, Chief Accounting Officer Common Stock 47K $894K $19.01 Oct 2, 2024 Direct

Insider Reports Filed by Michael P. Dube

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Oct 2, 2024 1 -$38.2K 4 Oct 4, 2024 VP, Chief Accounting Officer
NTLA Intellia Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 VP, PAO and Interim PFO
NTLA Intellia Therapeutics, Inc. Apr 10, 2024 0 $0 3 Apr 22, 2024 Principal Accounting Officer